Evidence map›Paper›PMID 36427927›Full record

ArticleSurgery2022

Use of fluorescence imaging and indocyanine green for sentinel node mapping during gastric cancer surgery: Results of an intercontinental Delphi survey.

Danny A Sherwinter, Luigi Boni, Michael Bouvet, Lorenzo Ferri, Woo Jin Hyung, Takeaki Ishizawa, Ronald N Kaleya, Kaitlyn Kelly, Norihiro Kokudo, Enrique Lanzarini and 19 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06421220 (Clinical Efficacy and Safety Evaluation of Submucosal Injection of Indocyanine Green Tracer in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer), which is not on this map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06421220 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Clinical Efficacy and Safety Evaluation of Submucosal Injection of Indocyanine Green Tracer in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer: a Prospective, a Multicenter, Randomized, Controlled Study Clinical Trial

TypeinterventionalSponsorQilu Hospital of Shandong UniversityRan2024 to 2028Enrolled484ConditionsGastric CancerArmsPreoperative injection of indocyanine green
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Fluorescence-guided lymphadenectomy in gastric cancer surgery: a novel intraoperative indocyanine green injection.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 9 countries.

Danny A SherwinterMaimonides Medical Center, Brooklyn, NY.
Luigi BoniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, University of Milan, Italy.
Michael BouvetUniversity of California-San Diego, San Diego, CA.
Lorenzo FerriMcGill University, Montreal, Quebec, Canada.
Woo Jin HyungSeverance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Takeaki IshizawaGraduate School of Medicine, University of Tokyo, Tokyo, Japan.
Ronald N KaleyaMaimonides Medical Center, Brooklyn, NY.
Kaitlyn KellyUniversity of California-San Diego, San Diego, CA.
Norihiro KokudoNational Center for Global Health and Medicine, Tokyo, Japan.
Enrique LanzariniHospital Clinico Universidad de Chile, Santiago, Chile.
Misha D P LuyerCatharina Hospital Eindhoven, the Netherlands.
Norio MitsumoriJikei University School of Medicine, Tokyo, Japan.
Carmen MuellerMcGill University, Montreal, Quebec, Canada.
Doo Joong ParkSeoul National University College of Medicine, Seoul, Korea.
Dario RiberoCandiolo Cancer Institute, Turin, Italy.
Riccardo RosatiSan Raffaele Hospital, Vita-Salute University, Milan, Italy.
Jelle P RuurdaUMC Utrecht Cancer Center, University Medical Center, Utrecht, the Netherlands.
Meindert SosefAtrium Medisch Centrum Parkstad, Heerlen, the Netherlands.
Sylke Schneider-KoraithKlinikum Suedstadt Rostock, Germany.
Giuseppe SpinoglioFPO Candolo Institute for Cancer Research and Treatment IRCCS, Turin, Italy.
Vivian StrongMemorial Sloan Kettering Cancer Center, New York, NY.
Naoto TakahashiJikei University School of Medicine, Tokyo, Japan.
Hiroya TakeuchiHamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Bas P L WijnhovenErasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
Han-Kwang YangSeoul National University Hospital, Seoul, Korea.
Fernando DipHospital de Clínicas José de San Martín, Buenos Aires, Argentina.
Emanuele Lo MenzoCleveland Clinic Florida, Weston, FL.
Kevin P WhiteScienceRight Research Consulting, London, Ontario, Canada.
Raul J RosenthalCleveland Clinic Florida, Weston, FL. Electronic address: rosentr@ccf.org.
Candiolo Cancer Institute · ITCleveland Clinic Florida · USJikei University School of Medicine · JPMaimonides Medical Center · USMcGill University · CAUniversity of California San Diego · USAtrium Medisch Centrum Parkstad · NLErasmus MC · NLHamamatsu University School of Medicine · JPHospital Clínico de la Universidad de Chile · CLHospital de Clínicas "José de San Martín" · ARKlinikum Südstadt Rostock · DEMemorial Sloan Kettering Cancer Center · USNational Center for Global Health and Medicine · JPRadboud University Nijmegen · NLSeoul National University · KRSeoul National University Hospital · KRThe University of Tokyo · JPUniversity Medical Center Utrecht · NLUniversity of Milan · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundUnderstanding the extent of tumor spread to local lymph nodes is critical to managing early-stage gastric cancer. Recently, fluorescence imaging with indocyanine green has been used to identify and characterize sentinel lymph nodes during gastric cancer surgery, but no published guidelines exist. We sought to identify areas of consensus among international experts in the use of fluorescence imaging with indocyanine green for mapping sentinel lymph nodes during gastric-cancer surgery.

methodsIn this 2-round, online Delphi survey, 27 international experts voted on 79 statements pertaining to patient preparation and contraindications to fluorescence imaging with indocyanine green during gastric cancer surgery; indications; technical aspects; advantages/disadvantages and limitations; and training and research. Methodological steps were adopted during survey design to minimize bias.

resultsConsensus was reached on 61 of 79 statements, including giving single injections of indocyanine green into each of the 4 quadrants peritumorally, administering indocyanine green on the same day as surgery, injecting a total of 1 to 5 mL of 5 mg/mL indocyanine green, injecting endoscopically into submucosa, and repeating indocyanine green injections a second time if sentinel lymph node visualization remains inadequate. Consensus also was reached that fluorescence imaging with indocyanine green is an acceptable single-agent modality for sentinel lymph node identification and that the sentinel lymph node basin method is preferred. However, sentinel lymph node dissection should be limited to T1 gastric cancer and tumors ≤4 cm in diameter, and further research is necessary to optimize the technique and render fluorescence-guided sentinel lymph nodes dissection acceptable for routine clinical use.

conclusionAlthough considerable consensus was achieved, further research is necessary before this technology should be used in routine practice.

Indexed as

Sentinel Lymph NodeStomach NeoplasmsHumansIndocyanine GreenOptical ImagingSentinel Lymph Node BiopsyIndocyanine Green

Identifiers

PMID36427927
PMCPMC9720539
OpenAlexW4309579149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.